Table 2.
Types of Carbon Nanotubes | Length (L)/Diameter (D) | Surface-Modified Complex | Cell Types | Mechanisms | Ref. |
---|---|---|---|---|---|
SWCNTs | L: >1 µm | Pluronic- F108:CNT | Macrophage cells | Phagocytosis | [156] |
SWCNTs MWCNTs |
30–400 nm | – | Murine macrophage RAW264.7 cells | Phagocytosis | [62] |
MWCNT | L: 453.5 ± 6.2 | C6-CNTPC | A549 cells | Phagocytosis | [20] |
SWCNTs | L:195–630 nm | – | Murine macrophage cells | Macropinocytosis | [60] |
MWCNTs | L: >300 nm | p(4VP)-MWCNTs | TT1 cells | Macropinocytosis | [7] |
SWCNTs | L: <500 nm/D: 1–2 nm | AO–SWCNTs | Hela cells | Clathrin-mediated endocytosis | [157] |
MWCNTs | L:10 µm/D: 60 nm | – | BEAS-2B cells, HBEpCs | Clathrin- and caveolae-mediated endocytosis | [158] |
SWNTs | L: 0.05–0.2 μm/<1 μm | SWNT-DNA, SWNT- proteins | HeLa cell | Clathrin-dependent endocytosis | [159] |
MWCNTs | D: ~200 nm | Oxidized -MWCNTs | Caco-2 cell | Clathrin-dependent endocytosis | [160] |
CNTs | L: 250–400 nm | PEG-CNT-ABT737 nanodrug | A549 non-small cell lung cancer cells | Clathrin-mediated endocytosis | [87] |
SWNTs | L: 100–200 nm/D: 1–3 nm | FA-SWNTs | HepG2 cells | Folate receptor mediated endocytosis | [161] |
SWNTs | L:50–100 nm/D: 1–3 nm | FA- SWNTs | HepG2 cells | Folate receptor mediated endocytosis | [162] |
MWCNTs | L: 3 lm to 10 lm/D: 50 nm – 300 nm | – | Human neonatal epidermal keratinocytes (HEK) | Lectin receptor mediated endocytic pathway | [163] |
SWCNTs | L: 50–200 nm/D: 1–3 nm | FA-SWCNTs | HepG2 cells | Passive diffusion for 50 nm or less SWNTs Clathrin-mediated endocytosis for 100–200 nm SWNTs |
[164] |
MWCNTs | D: 20–30 nm | FITC- MWCNTs | Plant cells | Passive diffusion | [165] |
Abbreviations: HBEpCs, human bronchial epithelial cells; FA, folate acid; C6-CNTPC, coumarin-6 loaded TPGS conjugated MWCNT.